Novo Nordisk
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2025-06-11
- Valid until
- still holds
- Published
- 2025-06-11
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · its source page states the value and the date
- Confidence
- 0.70
Sources
“GTC Paris at VivaTech —NVIDIA today announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.”— what the page says, read 2026-11-08
Cite this claim
Plain text
AsOf. "Nvidia partnership: Novo Nordisk", as of 2025-06-11. Claim clm_9BDCE06C7B01, https://asof.is/claim/clm_9BDCE06C7B01, accessed 2026-11-09. Source: https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery.
APA
AsOf. (2025). Nvidia partnership: Novo Nordisk (as of 2025-06-11) [Record clm_9BDCE06C7B01]. Retrieved November 9, 2026, from https://asof.is/claim/clm_9BDCE06C7B01 (source: https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery)
BibTeX
@misc{asof_clm_9BDCE06C7B01,
author = {AsOf},
title = {Nvidia partnership: Novo Nordisk},
year = {2025},
howpublished = {\url{https://asof.is/claim/clm_9BDCE06C7B01}},
note = {Claim clm\_9BDCE06C7B01, as of 2025-06-11; source: https://nvidianews.nvidia.com/news/nvidia-partners-with-novo-nordisk-and-dcai-to-advance-drug-discovery},
urldate = {2026-11-09}
}On the record
/claim/clm_9BDCE06C7B01.md/v1/claims/clm_9BDCE06C7B01submit a correction